{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:13:54Z","timestamp":1768716834904,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Innovative Medizinische Forschung"},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.humimm.2016.01.016","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T07:15:35Z","timestamp":1453878935000},"page":"727-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["CD4+HLA-G+ regulatory T cells: Molecular signature and pathophysiological relevance"],"prefix":"10.1016","volume":"77","author":[{"given":"Susann","family":"Pankratz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2016.01.016_b0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.immunol.21.120601.141107","article-title":"Positive and negative selection of T cells","volume":"21","author":"Starr","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2016.01.016_b0020","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","article-title":"HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation","volume":"110","author":"Feger","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.01.016_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.21705","article-title":"Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis","volume":"66","author":"Huang","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.humimm.2016.01.016_b0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1189\/jlb.1008649","article-title":"T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible","volume":"86","author":"Huang","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2016.01.016_b0035","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1096\/fj.14-251074","article-title":"Human CD4+HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo","volume":"28","author":"Pankratz","year":"2014","journal-title":"FASEB J."},{"issue":"144","key":"10.1016\/j.humimm.2016.01.016_b0040","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4049\/jimmunol.144.2.731","article-title":"Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule","volume":"1950","author":"Ellis","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/intimm\/11.6.889","article-title":"HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein","volume":"11","author":"Mallet","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0050","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0055","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","article-title":"The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G","volume":"55","author":"Cirulli","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.humimm.2016.01.016_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02930962","article-title":"Detection of HLA-G on human extravillous cytotrophoblast and skeletal muscle with a new monoclonal antibody MEM-G\/1","volume":"48","author":"Lodererov\u00e1","year":"2003","journal-title":"Folia Microbiol. (Praha)"},{"issue":"156","key":"10.1016\/j.humimm.2016.01.016_b0065","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.4049\/jimmunol.156.11.4224","article-title":"Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma","volume":"1950","author":"Yang","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","article-title":"IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes","volume":"11","author":"Moreau","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","article-title":"Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule","volume":"16","author":"Lozano","year":"2002","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.humimm.2016.01.016_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.09.016","article-title":"Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis","volume":"159","author":"Mitsdoerffer","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.01.016_b0090","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3324\/haematol.2011.055871","article-title":"Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites","volume":"97","author":"Lazana","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2016.01.016_b0095","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0198-8859(00)00197-X","article-title":"Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells","volume":"61","author":"Paul","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0100","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2003.11.153","article-title":"Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis","volume":"313","author":"Park","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.humimm.2016.01.016_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/immu.200390015","article-title":"Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation","volume":"33","author":"Contini","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0110","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/blood-2005-12-019919","article-title":"Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells","volume":"108","author":"Fons","year":"2006","journal-title":"Blood"},{"issue":"160","key":"10.1016\/j.humimm.2016.01.016_b0115","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.4049\/jimmunol.160.7.3096","article-title":"Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules","volume":"1950","author":"Colonna","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.01.016_b0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2172-8-12","article-title":"CD8\u03b1 is expressed by human monocytes and enhances Fc\u03b3R-dependent responses","volume":"8","author":"Gibbings","year":"2007","journal-title":"BMC Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10408363.2012.677947","article-title":"The immunosuppressive molecule HLA-G and its clinical implications","volume":"49","author":"Gonz\u00e1lez","year":"2012","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.humimm.2016.01.016_b0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0140","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1073\/pnas.0401922101","article-title":"HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells","volume":"101","author":"LeMaoult","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2016.01.016_b0145","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M","article-title":"Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro","volume":"31","author":"Stephens","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0150","first-page":"285","article-title":"Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells","volume":"109","author":"Jonuleit","year":"2005","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.humimm.2016.01.016_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2172-9-63","article-title":"Study of membrane potential in T lymphocytes subpopulations using flow cytometry","volume":"9","author":"de Queiroz","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0160","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humimm.2010.05.002","article-title":"Membrane potential of CD4+ T cells is a subset specific feature that depends on the direct cell-to-cell contacts with monocytes","volume":"71","author":"Marek","year":"2010","journal-title":"Hum. Immunol."},{"issue":"167","key":"10.1016\/j.humimm.2016.01.016_b0165","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"1950","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"issue":"169","key":"10.1016\/j.humimm.2016.01.016_b0170","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.4049\/jimmunol.169.11.6210","article-title":"Inhibition of human CD4(+)CD25(+high) regulatory T cell function","volume":"1950","author":"Baecher-Allan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1189\/jlb.0605344","article-title":"Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells","volume":"80","author":"Tsang","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2016.01.016_b0180","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2006-07-035279","article-title":"Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells","volume":"109","author":"Crellin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.01.016_b0185","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.01.016_b0190","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.01.016_b0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1615\/CritRevImmunol.v32.i1.40","article-title":"Regulation generation: the suppressive functions of human regulatory T cells","volume":"32","author":"Goodman","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0200","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.smim.2011.04.003","article-title":"Making sense of regulatory T cell suppressive function","volume":"23","author":"Shalev","year":"2011","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0205","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2009-02-206730","article-title":"Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells","volume":"114","author":"Becker","year":"2009","journal-title":"Blood"},{"issue":"188","key":"10.1016\/j.humimm.2016.01.016_b0210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.1102045","article-title":"Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells","volume":"1950","author":"Klein","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0215","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.01.016_b0220","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1086\/596205","article-title":"CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice","volume":"199","author":"Alam","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2016.01.016_b0225","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/brain\/awh609","article-title":"Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity","volume":"128","author":"Wiendl","year":"2005","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.humimm.2016.01.016_b0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.humimm.2006.10.021","article-title":"HLA-G in the nervous system","volume":"68","author":"Wiendl","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/WNL.0b013e318228c14d","article-title":"Evaluation of soluble HLA-G as a biomarker for multiple sclerosis","volume":"77","author":"Waschbisch","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.humimm.2016.01.016_b0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/1352458506ms1241oa","article-title":"Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis","volume":"12","author":"Fainardi","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.humimm.2016.01.016_b0245","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1352458507085137","article-title":"CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing\u2014remitting","volume":"14","author":"Fainardi","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.humimm.2016.01.016_b0250","article-title":"Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis","author":"Fainardi","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.humimm.2016.01.016_b0255","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1002\/eji.201040558","article-title":"Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis","volume":"40","author":"Schneider-Hohendorf","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0260","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.01.016_b0265","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0270","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients","volume":"147","author":"Feger","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"179","key":"10.1016\/j.humimm.2016.01.016_b0275","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.179.2.1322","article-title":"Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis","volume":"1950","author":"Haas","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0280","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humimm.2009.07.014","article-title":"Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis","volume":"70","author":"Fainardi","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0285","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(00)02386-2","article-title":"Implication of HLA-G molecule in heart-graft acceptance","volume":"355","author":"Lila","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2016.01.016_b0290","doi-asserted-by":"crossref","first-page":"e1003140","DOI":"10.1371\/journal.ppat.1003140","article-title":"Functional characterization of HLA-G+ regulatory T cells in HIV-1 infection","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.humimm.2016.01.016_b0295","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.humimm.2012.11.031","article-title":"HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy","volume":"74","author":"Amodio","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.healun.2007.01.001","article-title":"Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation","volume":"26","author":"Lila","year":"2007","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2016.01.016_b0305","first-page":"2652","article-title":"HLA-G expression in the peripheral blood of live kidney transplant recipients","volume":"126","author":"Xiao","year":"2013","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.humimm.2016.01.016_b0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fimmu.2013.00163","article-title":"The role of regulatory T cells in the biology of graft versus host disease","volume":"4","author":"Beres","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0315","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1432-2277.2011.01314.x","article-title":"HLA-G on peripheral blood CD4(+) T lymphocytes: a potential predictor for acute renal rejection","volume":"24","author":"Lu","year":"2011","journal-title":"Transpl. Int."},{"key":"10.1016\/j.humimm.2016.01.016_b0320","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2006.09.012","article-title":"Interferon beta-1a therapy enhances CD4 regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis","volume":"182","author":"de Andr\u00e9s","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.humimm.2016.01.016_b0325","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.3390\/ijms160716330","article-title":"Interferon-beta therapy of multiple sclerosis patients improves the responsiveness of T cells for immune suppression by regulatory T cells","volume":"16","author":"Trinschek","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2016.01.016_b0330","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2012.71","article-title":"Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells","volume":"20","author":"Andolfi","year":"2012","journal-title":"Mol. Ther."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T16:41:12Z","timestamp":1692204072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0198885916000252"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.01.016","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4+HLA-G+ regulatory T cells: Molecular signature and pathophysiological relevance","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}